Economic analyses of genetic tests in personalized medicine: clinical utility first, then cost utility

Scott D. Grosse PhD

Genetics in Medicine

(2014)

16,

225–227

doi:10.1038/gim.2013.158

Received: 28 August 2013
Accepted: 04 September 2013
Published online: 10 October 2013

In the current issue of Genetics in Medicine, Phillips et al.¹ report a thorough systematic review of published cost-utility analyses (CUAs) of clinical molecular genetic tests, or personalized medicine tests as the authors refer to them. By analyzing the Tufts Cost-Effectiveness Analysis Registry, the authors identified 59 CUAs published from…